Sökning: onr:"swepub:oai:lup.lub.lu.se:352a4e8d-2cb5-46dd-9c77-358b037d4e3f" >
Low-density lipopro...
Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes : A Swedish nationwide cohort study
-
- Schubert, Jessica (författare)
- Uppsala universitet,Uppsala University,Kardiologi
-
- Lindahl, Bertil, 1957- (författare)
- Uppsala universitet,Uppsala University,Uppsala University Hospital,Uppsala kliniska forskningscentrum (UCR),Kardiologi,UCR
-
- Melhus, Håkan (författare)
- Uppsala universitet,Uppsala University,Klinisk farmakogenomik och osteoporos
-
visa fler...
-
- Renlund, Henrik, 1979- (författare)
- Uppsala universitet,Uppsala kliniska forskningscentrum (UCR)
-
- Leosdottir, Margrét (författare)
- Lund University,Lunds universitet,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,Internal Medicine - Epidemiology,Lund University Research Groups,Department of Cardiology, Skåne University Hospital, Malmö, Sweden;Department of Clinical Sciences, Faculty of Medicine, Lund University, Malmö, Sweden
-
- Yari, Ali (författare)
- Karolinska Institutet,Karolinska Institute,Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden
-
- Ueda, Peter (författare)
- Karolinska Institutet,Karolinska Institute,Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
-
- James, Stefan, 1964- (författare)
- Uppsala universitet,Uppsala University,Uppsala University Hospital,Uppsala kliniska forskningscentrum (UCR),Kardiologi
-
- Reading, Stephanie R. (författare)
- Amgen, Inc, Thousand Oaks, CA, USA
-
- Dluzniewski, Paul J. (författare)
- Amgen, Inc, Thousand Oaks, CA, USA
-
- Hamer, Andrew W. (författare)
- Amgen, Inc, Thousand Oaks, CA, USA
-
- Jernberg, Tomas (författare)
- Karolinska Institutet,Karolinska Institute,Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden
-
- Hagström, Emil (författare)
- Uppsala universitet,Uppsala University,Uppsala University Hospital,Uppsala kliniska forskningscentrum (UCR),Kardiologi
-
visa färre...
-
(creator_code:org_t)
- 2020-12-24
- 2021
- Engelska 10 s.
-
Ingår i: European Heart Journal. - : Oxford University Press (OUP). - 0195-668X .- 1522-9645. ; 42:3, s. 243-252
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://academic.oup...
-
https://doi.org/10.1...
-
https://uu.diva-port... (primary) (Raw object)
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Aims: Clinical trials have demonstrated that a reduction in low-density lipoprotein cholesterol (LDL-C) reduces cardiovascular (CV) events. This has, however, not yet been shown in a real-world setting. We aimed to investigate the association between LDL-C changes and statin intensity with prognosis after a myocardial infarction (MI). Methods and results: Patients admitted with MI were followed for mortality and major CV events. Changes in LDL-C between the MI and a 6-to 10-week follow-up visit were analysed. The associations between quartiles of LDL-C change and statin intensity with outcomes were assessed using adjusted Cox regression analyses. A total of 40 607 patients were followed for a median of 3.78 years. The median change in LDL-C was a 1.20 mmol/L reduction. Patients with larger LDL-C reduction (1.85 mmol/L, 75th percentile) compared with a smaller reduction (0.36 mmol/L, 25th percentile) had lower hazard ratios (HR) for all outcomes (95% confidence interval): composite of CV mortality, MI, and ischaemic stroke 0.77 (0.70-0.84); all-cause mortality 0.71 (0.63-0.80); CV mortality 0.68 (0.57-0.81); MI 0.81 (0.73-0.91); ischaemic stroke 0.76 (0.62-0.93); heart failure hospitalization 0.73 (0.63-0.85), and coronary artery revascularization 0.86 (0.79-0.94). Patients with ≥50% LDL-C reduction using high-intensity statins at discharge had a lower incidence of all outcomes compared with those using a lower intensity statin. Conclusions: Larger early LDL-C reduction and more intensive statin therapy after MI were associated with a reduced hazard of all CV outcomes and all-cause mortality. This supports clinical trial data suggesting that earlier lowering of LDL-C after an MI confers the greatest benefit.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- Cardiovascular mortality
- Cardiovascular outcomes
- LDL-C
- Myocardial infarction
- Secondary prevention
- Statin
- Cardiovascular mortality
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Schubert, Jessic ...
-
Lindahl, Bertil, ...
-
Melhus, Håkan
-
Renlund, Henrik, ...
-
Leosdottir, Marg ...
-
Yari, Ali
-
visa fler...
-
Ueda, Peter
-
James, Stefan, 1 ...
-
Reading, Stephan ...
-
Dluzniewski, Pau ...
-
Hamer, Andrew W.
-
Jernberg, Tomas
-
Hagström, Emil
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
European Heart J ...
- Av lärosätet
-
Lunds universitet
-
Uppsala universitet
-
Karolinska Institutet